Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
37
AEVA Quote, Financials, Valuation and Earnings
Last price:
$30.66
Seasonality move
:
-21.36%
Day range:
$27.85 - $31.43
52-week range:
$2.36 - $38.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
160.03x
P/B ratio:
24.53x
Volume:
3.6M
Avg. volume:
3M
1-year change:
807.69%
Market cap:
$1.7B
Revenue:
$9.1M
EPS (TTM):
-$2.83
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.8M | $9.3M | $4.2M | $4.3M | $9.1M | |
| Revenue Growth (YoY) | 249.93% | 91.31% | -54.76% | 2.86% | 110.23% | |
| Cost of Revenues | $2.7M | $5.8M | $8.4M | $10.2M | $12.9M | |
| Gross Profit | $2.1M | $3.4M | -$4.3M | -$5.9M | -$3.8M | |
| Gross Profit Margin | 43.4% | 37.04% | -101.5% | -136.5% | -41.81% | |
| R&D Expenses | $20.5M | $74.8M | $109.6M | $102.5M | $102.7M | |
| Selling, General & Admin | $7.3M | $32.9M | $38.1M | $39.4M | $40.4M | |
| Other Inc / (Exp) | -$24K | $1.9M | $943K | -$10.5M | -$12.9M | |
| Operating Expenses | $27.8M | $107.6M | $147.7M | $141.9M | $143.1M | |
| Operating Income | -$25.7M | -$104.2M | -$152M | -$147.8M | -$146.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$25.6M | -$101.9M | -$147.3M | -$149.3M | -$152.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $171K | |
| Net Income to Company | -$25.6M | -$101.9M | -$147.3M | -$149.3M | -$152.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$25.6M | -$101.9M | -$147.3M | -$149.3M | -$152.3M | |
| Basic EPS (Cont. Ops) | -$0.60 | -$2.55 | -$3.39 | -$3.29 | -$2.85 | |
| Diluted EPS (Cont. Ops) | -$0.60 | -$2.55 | -$3.39 | -$3.29 | -$2.85 | |
| Weighted Average Basic Share | $42.3M | $40.2M | $43.5M | $45.4M | $53.4M | |
| Weighted Average Diluted Share | $42.3M | $40.2M | $43.5M | $45.4M | $53.4M | |
| EBITDA | -$24.9M | -$101.1M | -$145.8M | -$140.1M | -$137.9M | |
| EBIT | -$25.7M | -$104.2M | -$152M | -$147.8M | -$146.9M | |
| Revenue (Reported) | $4.8M | $9.3M | $4.2M | $4.3M | $9.1M | |
| Operating Income (Reported) | -$25.7M | -$104.2M | -$152M | -$147.8M | -$146.9M | |
| Operating Income (Adjusted) | -$25.7M | -$104.2M | -$152M | -$147.8M | -$146.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $308K | $1.1M | $1.1M | $2.1M | $3.4M | |
| Revenue Growth (YoY) | -41.56% | 269.16% | 0.97% | 83.54% | 59.85% | |
| Cost of Revenues | $180K | $1.4M | $2.5M | $3.5M | $3.1M | |
| Gross Profit | $128K | -$238K | -$1.4M | -$1.4M | $310K | |
| Gross Profit Margin | 41.56% | -20.93% | -120.3% | -66.07% | 9.2% | |
| R&D Expenses | $11.4M | $25.3M | $25.5M | $25M | $21.6M | |
| Selling, General & Admin | $8.9M | $8.5M | $10.4M | $10.9M | $9.2M | |
| Other Inc / (Exp) | $666K | $633K | $28K | -$439K | -$5.4M | |
| Operating Expenses | $20.3M | $33.8M | $35.9M | $36M | $30.7M | |
| Operating Income | -$20.1M | -$34.1M | -$37.3M | -$37.3M | -$30.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$19.5M | -$33.2M | -$35.2M | -$35.3M | -$34.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $57K | |
| Net Income to Company | -$19.5M | -$33.2M | -$35.2M | -$35.3M | -$34.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$19.5M | -$33.2M | -$35.2M | -$35.3M | -$34.9M | |
| Basic EPS (Cont. Ops) | -$0.60 | -$0.75 | -$0.80 | -$0.67 | -$0.64 | |
| Diluted EPS (Cont. Ops) | -$0.60 | -$0.75 | -$0.80 | -$0.67 | -$0.64 | |
| Weighted Average Basic Share | $32.8M | $43.2M | $43.9M | $52.7M | $54.8M | |
| Weighted Average Diluted Share | $32.8M | $43.2M | $43.9M | $52.7M | $54.8M | |
| EBITDA | -$19.7M | -$32.7M | -$35.6M | -$35.2M | -$28.1M | |
| EBIT | -$20.1M | -$34.1M | -$37.3M | -$37.3M | -$30.4M | |
| Revenue (Reported) | $308K | $1.1M | $1.1M | $2.1M | $3.4M | |
| Operating Income (Reported) | -$20.1M | -$34.1M | -$37.3M | -$37.3M | -$30.4M | |
| Operating Income (Adjusted) | -$20.1M | -$34.1M | -$37.3M | -$37.3M | -$30.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.6M | $10.1M | $4.2M | $5.3M | $10.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.6M | $7M | $9.6M | $11.2M | $12.4M | |
| Gross Profit | $2M | $3.1M | -$5.4M | -$5.9M | -$2.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $26.6M | $88.7M | $109.7M | $102.1M | $99.2M | |
| Selling, General & Admin | $14.3M | $32.5M | $40M | $39.9M | $38.6M | |
| Other Inc / (Exp) | $659K | $1.9M | $338K | -$10.9M | -$17.9M | |
| Operating Expenses | $40.9M | $121.2M | $149.8M | $142M | $137.9M | |
| Operating Income | -$38.9M | -$118.1M | -$155.1M | -$147.9M | -$139.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$38.2M | -$115.6M | -$149.3M | -$149.5M | -$151.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $228K | |
| Net Income to Company | -$38.2M | -$115.6M | -$149.3M | -$149.5M | -$151.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$38.2M | -$115.6M | -$149.3M | -$149.5M | -$151.8M | |
| Basic EPS (Cont. Ops) | -$1.04 | -$2.70 | -$3.45 | -$3.14 | -$2.83 | |
| Diluted EPS (Cont. Ops) | -$1.04 | -$2.70 | -$3.45 | -$3.14 | -$2.83 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$37.8M | -$114.1M | -$148.6M | -$139.6M | -$130.9M | |
| EBIT | -$38.9M | -$118.1M | -$155.1M | -$147.9M | -$139.9M | |
| Revenue (Reported) | $4.6M | $10.1M | $4.2M | $5.3M | $10.3M | |
| Operating Income (Reported) | -$38.9M | -$118.1M | -$155.1M | -$147.9M | -$139.9M | |
| Operating Income (Adjusted) | -$38.9M | -$118.1M | -$155.1M | -$147.9M | -$139.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $308K | $1.1M | $1.1M | $2.1M | $3.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $180K | $1.4M | $2.5M | $3.5M | $3.1M | |
| Gross Profit | $128K | -$238K | -$1.4M | -$1.4M | $310K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $11.4M | $25.3M | $25.5M | $25M | $21.6M | |
| Selling, General & Admin | $8.9M | $8.5M | $10.4M | $10.9M | $9.2M | |
| Other Inc / (Exp) | $666K | $633K | $28K | -$439K | -$5.4M | |
| Operating Expenses | $20.3M | $33.8M | $35.9M | $36M | $30.7M | |
| Operating Income | -$20.1M | -$34.1M | -$37.3M | -$37.3M | -$30.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$19.5M | -$33.2M | -$35.2M | -$35.3M | -$34.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $57K | |
| Net Income to Company | -$19.5M | -$33.2M | -$35.2M | -$35.3M | -$34.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$19.5M | -$33.2M | -$35.2M | -$35.3M | -$34.9M | |
| Basic EPS (Cont. Ops) | -$0.60 | -$0.75 | -$0.80 | -$0.67 | -$0.64 | |
| Diluted EPS (Cont. Ops) | -$0.60 | -$0.75 | -$0.80 | -$0.67 | -$0.64 | |
| Weighted Average Basic Share | $32.8M | $43.2M | $43.9M | $52.7M | $54.8M | |
| Weighted Average Diluted Share | $32.8M | $43.2M | $43.9M | $52.7M | $54.8M | |
| EBITDA | -$19.7M | -$32.7M | -$35.6M | -$35.2M | -$28.1M | |
| EBIT | -$20.1M | -$34.1M | -$37.3M | -$37.3M | -$30.4M | |
| Revenue (Reported) | $308K | $1.1M | $1.1M | $2.1M | $3.4M | |
| Operating Income (Reported) | -$20.1M | -$34.1M | -$37.3M | -$37.3M | -$30.4M | |
| Operating Income (Adjusted) | -$20.1M | -$34.1M | -$37.3M | -$37.3M | -$30.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $24.6M | $66.8M | $67.4M | $38.5M | $28.9M | |
| Short Term Investments | -- | $378.2M | $256.4M | $182.5M | $83.1M | |
| Accounts Receivable, Net | $141K | $2.3M | $2.9M | $628K | $1.2M | |
| Inventory | $1.2M | $2.1M | $3M | $2.4M | $2.3M | |
| Prepaid Expenses | $1.3M | $3.9M | $3.7M | $3.3M | $3.3M | |
| Other Current Assets | -- | $1.1M | $1.5M | $1.7M | $4.4M | |
| Total Current Assets | $31M | $458.5M | $335.1M | $229.2M | $123.3M | |
| Property Plant And Equipment | $1.6M | $15.4M | $17.1M | $19.4M | $14.2M | |
| Long-Term Investments | -- | -- | -- | $5M | $5M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $64K | $859K | $8K | $16K | $2.5M | |
| Total Assets | $32.6M | $479.2M | $356.6M | $257.4M | $147.5M | |
| Accounts Payable | $2.1M | $4.4M | $5.2M | $3.6M | $5.5M | |
| Accrued Expenses | $2.6M | $4.1M | $9.1M | $2.6M | $5.7M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $2.9M | $2.7M | $3.6M | $3M | |
| Other Current Liabilities | $44K | $182K | $194K | $448K | $15.2M | |
| Total Current Liabilities | $5.7M | $14.3M | $21.8M | $18.4M | $39.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.7M | $22.8M | $26.7M | $28.9M | $48.1M | |
| Common Stock | $15K | $21K | $22K | $5K | $6K | |
| Other Common Equity Adj | -- | -$524K | -$3.6M | -$87K | $47K | |
| Common Equity | $26.9M | $456.4M | $329.9M | $228.4M | $99.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $26.9M | $456.4M | $329.9M | $228.4M | $99.4M | |
| Total Liabilities and Equity | $32.6M | $479.2M | $356.6M | $257.4M | $147.5M | |
| Cash and Short Terms | $24.6M | $445M | $323.8M | $221M | $112M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $469.4M | $62.5M | $31.9M | $29.6M | $21.2M | |
| Short Term Investments | $53.5M | $352M | $256.5M | $159.7M | $59.8M | |
| Accounts Receivable, Net | $245K | $211K | $2.4M | $978K | $775K | |
| Inventory | $1.5M | $1.9M | $3M | $2.2M | $3.9M | |
| Prepaid Expenses | $1.4M | $2.8M | $2.5M | $3.2M | $2.7M | |
| Other Current Assets | $53K | $886K | $1.8M | $1.6M | $3.4M | |
| Total Current Assets | $526.7M | $425.3M | $298.5M | $197.4M | $91.8M | |
| Property Plant And Equipment | $8.4M | $16.9M | $17.3M | $19M | $15.3M | |
| Long-Term Investments | -- | -- | -- | $5M | $5M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $3.3M | -- | -- | |
| Other Long-Term Assets | $360K | $860K | $862K | -- | $191K | |
| Total Assets | $535.5M | $447.2M | $320M | $224.8M | $114.5M | |
| Accounts Payable | $2.6M | $6.6M | $3.9M | $3.4M | $4M | |
| Accrued Expenses | $1.8M | $2.7M | $3.9M | $2.6M | $4.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.3M | $2.9M | $2.5M | $3.7M | $2.6M | |
| Other Current Liabilities | $31K | $167K | $194K | $4.4M | $14.9M | |
| Total Current Liabilities | $6.4M | $13.6M | $13.9M | $16.6M | $31.9M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $13.6M | $20.7M | $18.1M | $26.6M | $45.7M | |
| Common Stock | $21K | $22K | $22K | $5K | $6K | |
| Other Common Equity Adj | -$29K | -$3M | -$2.4M | -$248K | -$7K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $521.9M | $426.5M | $302M | $198.2M | $68.8M | |
| Total Liabilities and Equity | $535.5M | $447.2M | $320M | $224.8M | $114.5M | |
| Cash and Short Terms | $522.9M | $414.5M | $288.4M | $189.3M | $81M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$25.6M | -$101.9M | -$147.3M | -$149.3M | -$152.3M | |
| Depreciation & Amoritzation | $798K | $3.1M | $6.1M | $7.7M | $8.9M | |
| Stock-Based Compensation | $3.8M | $22.2M | $24.2M | $23.7M | $23.7M | |
| Change in Accounts Receivable | $228K | -$2.2M | -$546K | $2.3M | -$559K | |
| Change in Inventories | -$865K | -$844K | -$2.6M | $353K | -$1.1M | |
| Cash From Operations | -$21.2M | -$82.1M | -$109.9M | -$118.8M | -$106.9M | |
| Capital Expenditures | $855K | $8.4M | $7.4M | $6.1M | $5.1M | |
| Cash Acquisitions | -- | -- | -- | -$5M | -- | |
| Cash From Investing | -$855K | -$388.6M | $110.9M | $69.3M | $97.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $512M | -$720K | -$1M | -$752K | |
| Cash From Financing | $73K | $512.9M | -$369K | $20.7M | -$671K | |
| Beginning Cash (CF) | $46.6M | $24.6M | $66.8M | $67.4M | $38.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$22M | $42.2M | $610K | -$28.9M | -$9.7M | |
| Ending Cash (CF) | $24.6M | $66.8M | $67.4M | $38.5M | $28.9M | |
| Levered Free Cash Flow | -$22.1M | -$90.5M | -$117.4M | -$124.9M | -$112M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$19.5M | -$33.2M | -$35.2M | -$35.3M | -$34.9M | |
| Depreciation & Amoritzation | $438K | $1.3M | $1.7M | $2.2M | $2.3M | |
| Stock-Based Compensation | $4.5M | $5.8M | $6M | $5.3M | $4.6M | |
| Change in Accounts Receivable | -$104K | $2.1M | $442K | -$350K | $412K | |
| Change in Inventories | -$310K | -$312K | -$100K | -$251K | -$1.6M | |
| Cash From Operations | -$14.8M | -$26.5M | -$36M | -$31M | -$30.8M | |
| Capital Expenditures | $669K | $1.3M | $1.3M | $1.6M | $459K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$54.2M | $22M | $419K | $22M | $23.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $513.5M | -- | -$20K | -$55K | -$183K | |
| Cash From Financing | $513.7M | $187K | $37K | -$16K | -$183K | |
| Beginning Cash (CF) | $24.6M | $66.8M | $67.4M | $38.5M | $28.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $444.8M | -$4.3M | -$35.6M | -$8.9M | -$7.7M | |
| Ending Cash (CF) | $469.4M | $62.5M | $31.9M | $29.6M | $21.2M | |
| Levered Free Cash Flow | -$15.5M | -$27.8M | -$37.3M | -$32.6M | -$31.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$38.2M | -$115.6M | -$149.3M | -$149.5M | -$151.8M | |
| Depreciation & Amoritzation | $1M | $4M | $6.5M | $8.2M | $9M | |
| Stock-Based Compensation | $7.4M | $23.5M | $24.4M | $23M | $23M | |
| Change in Accounts Receivable | $104K | $34K | -$2.2M | $1.5M | $203K | |
| Change in Inventories | -$976K | -$846K | -$2.3M | $202K | -$2.4M | |
| Cash From Operations | -$30.3M | -$93.8M | -$119.4M | -$113.8M | -$106.7M | |
| Capital Expenditures | $1.3M | $9M | $7.4M | $6.5M | $3.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$54.8M | -$312.4M | $89.3M | $90.9M | $99.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$740K | -$1.1M | -$880K | |
| Cash From Financing | $513.8M | -$697K | -$519K | $20.6M | -$838K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $428.7M | -$406.9M | -$30.6M | -$2.3M | -$8.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$31.6M | -$102.8M | -$126.8M | -$120.3M | -$110.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$19.5M | -$33.2M | -$35.2M | -$35.3M | -$34.9M | |
| Depreciation & Amoritzation | $438K | $1.3M | $1.7M | $2.2M | $2.3M | |
| Stock-Based Compensation | $4.5M | $5.8M | $6M | $5.3M | $4.6M | |
| Change in Accounts Receivable | -$104K | $2.1M | $442K | -$350K | $412K | |
| Change in Inventories | -$310K | -$312K | -$100K | -$251K | -$1.6M | |
| Cash From Operations | -$14.8M | -$26.5M | -$36M | -$31M | -$30.8M | |
| Capital Expenditures | $669K | $1.3M | $1.3M | $1.6M | $459K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$54.2M | $22M | $419K | $22M | $23.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $513.5M | -- | -$20K | -$55K | -$183K | |
| Cash From Financing | $513.7M | $187K | $37K | -$16K | -$183K | |
| Beginning Cash (CF) | $24.6M | $66.8M | $67.4M | $38.5M | $28.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $444.8M | -$4.3M | -$35.6M | -$8.9M | -$7.7M | |
| Ending Cash (CF) | $469.4M | $62.5M | $31.9M | $29.6M | $21.2M | |
| Levered Free Cash Flow | -$15.5M | -$27.8M | -$37.3M | -$32.6M | -$31.3M | |
Get AEVA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AEVA
Sector
P/E ratio
--
23.75x
PEG ratio
-0.16x
0.00x
P/B ratio
24.53x
2.35x
Price / LTM sales
160.03x
1.66x
Growth Metrics
AEVA
Sector
Revenue growth
59.85%
3.91%
Earnings growth
--
11.1%
Revenue (5-year growth)
45.63%
6.27%
Earnings forecast
-$0.47
$0.12
Profitability
AEVA
Sector
Profitability FY 2024
-$3.8M
$76.5M
Return on invested capital
-115.78%
0.05%
Return on assets
-88.87%
-0.48%
Return on equity
-115.78%
0.73%
Earnings Date
Last Earnings Date
May
14
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
13
Balance Sheet
AEVA
Sector
Total cash
$81M
$48.7M
Short term investments
$83.1M
$19.4M
Total assets
$147.5M
$223.8M
Long term debt
--
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
